Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

scales

Standardising the pharma benefit-risk assessment process

September 1, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, benefit-risk analysis, pharmacoepidemiology, pharmacovigilance

Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view …
Feature
mytrus_cartoon

NHS approves electronic consent technology in clinical trials

August 28, 2015 Medical Communications, Research and Development Mytrus, NHS, clinical trials, digital health technology, electronic informed consent

Clinical technology and services company Mytrus has announced that its software platform for electronic informed consent has received approval for …
News

FDA approves Amgen’s cholesterol lowering drug

August 28, 2015 Medical Communications, Research and Development Amgen, FDA, Repatha, evolocumab

The FDA has endorsed Amgen’s cholesterol-lowering medication, Repatha, for the use in patients with high cholesterol. It follows Amgen’s successful …
News
Sanofi's go meals app

Moves in pharma app market, but user longevity an issue

August 28, 2015 Medical Communications Communication, apps, digital, medcomms, medical communications, mobile

Pharma companies continue to invest in the mobile app market, but studies have found that pharma apps suffer the same …
News
ESC congress sign

NHS looks to ESC for next-gen heart drug data

August 28, 2015 Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent

New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs …
News

Novo Nordisk to buy two pharma research companies

August 27, 2015 Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions

Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …
News

Cally Clarkson joins GCI Health as first director of medical education

August 27, 2015 Medical Communications Cally Clarkson, GCI Health

GCI Health has appointed Cally Clarkson as its first ever director of medical education.  Cally is based in GCI Health’s …
Appointment

Vicky Smith promoted to senior account executive at Liberation Unlimited

August 27, 2015 Medical Communications Vicki Smith, liberation unlimited

Liberation Unlimited has promoted Vicky Smith to senior account executive.Vicky joined Liberation Unlimited in 2013, and has since played an …
Appointment
cml

NHS restriction of CML treatment in England criticised

August 27, 2015 Medical Communications, Sales and Marketing NHS, NICE, chronic myeloid leukaemia, leukaemia

Medical experts have criticised NHS cost regulators’ decision to limit the use of Ariad’s Iclusig (ponatinib) in the treatment of …
News

Takeda gets European MAA approval for ixazomib

August 21, 2015 Medical Communications, Research and Development (FDA/EMA/MHRA), FDA/EMA/MHRA, Takeda, ixazomib, multiple myeloma

Takeda has announced that the European Medicines Agency (EMA) has accepted its Marketing Authorisation Application (MAA) for ixazomib, an investigational …
News
novartis

Novartis buys rights to GSK MS drug for up to $1 billion

August 21, 2015 Medical Communications, Research and Development, Sales and Marketing GlaxoSmithKline, Novartis, multiple sclerosis, ofatumumab

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline’s …
News
lilly_corporate_hq

Lilly and Boehringer’s Jardiance diabetes drug reduces cardiovascular risks

August 21, 2015 Medical Communications, Research and Development Boehringer Ingelheim, Eli Lilly, diabetes drugs

Eli Lilly’s diabetes drug Jardiance (empagliflozin) has shown in a study to be the very first blood sugar lowering drug …
News
sun_pharma_hq

Sun Pharma gets FDA approval for acne treatment

August 21, 2015 Medical Communications, Research and Development, Sales and Marketing Sun Pharma. acne treatments, drug approvals

The FDA has approved Sun Pharma’s new acne treatment, Ximino.The Ximino (minocycline hydrochloride) extended-release capsules, which will be available in …
News
259612

Monique Levy joins Google’s healthcare advisory board

August 20, 2015 Medical Communications google

Monique Levy, vice president of digital innovation at healthcare data and analytics firm Decision Resources Group, is joining Google’s healthcare …
Appointment
car_t-cells

Kite Pharma says trial death was unrelated to KTE-C19

August 18, 2015 Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma

Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026